Modulation by cyclic AMP in vitro of liver plasma membrane (Na+--K+)-ATPase and protein kinases.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D003600:Cytosol / Q000201:enzymology; D004837:Epinephrine / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000201:enzymology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism*; D012964:Sodium; D013806:Theophylline / Q000494:pharmacology
D002087:Butyrates; D003597:Cytosine Nucleotides; D009712:Nucleotides, Cyclic; D002110:Caffeine; D003994:Bucladesine; D012964:Sodium; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D011494:Protein Kinases; D000251:Adenosine Triphosphatases; D006152:Cyclic GMP; D008274:Magnesium; D011188:Potassium; D004837:Epinephrine